Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 19, 2026Clinical Cancer Research

Abstract PS3-05-22: Real-world adherence to germline genetic testing guidelines in breast cancer: patterns and disparities in a community oncology setting

View Full Paper
Ask AI
Bookmark
Share

Authors

LSL. ShahidAPA. J. PatevMDM. A. Danso

Discussion

Loading...

Member takes

Overview

This retrospective review identifies patterns in genetic testing adherence among breast cancer patients, highlighting disparities based on social factors.

Key Points

  • This research aims to evaluate adherence to genetic testing guidelines in breast cancer and explore the impact of social determinants on testing rates.
  • Retrospective chart review of breast cancer patients at Sentara Norfolk General Hospital from June 2019 to June 2024.
  • Sample includes 89 patients aged 36 to 65, predominantly female.
  • Patient eligibility was assessed based on NCCN guidelines for genetic testing.
  • Demographic information regarding race, marital status, and insurance was collected.
  • 75% of the patients received genetic testing orders (67 out of 89).
  • 65 patients completed the genetic testing.
  • Testing completion varied by race: 92% of eligible White patients completed testing compared to 77% of eligible Black patients.
  • 87% of married patients completed testing compared to 70% of single patients.

Cite This Study

Shahid et al. (2026) studied this question.

synapsesocial.com/papers/6996a8a9ecb39a600b3efa43https://doi.org/10.1158/1557-3265.sabcs25-ps3-05-22
View Full Paper
Ask AI
Bookmark
Share